Industry: Food & Beverages
Published Date: 2026-03-05
Pages: 108 Pages
Report ld: 6008082
Request Sample
Customized Report
Human Milk Oligosaccharides Market Size(US$)

CAGR 2026-2032
3.4%
Market Size,2032
USD 537
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Human Milk Oligosaccharides market was valued at US$ 425 million in 2025 and is anticipated to reach US$ 537 million by 2032, at a CAGR of 3.4% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Human Milk Oligosaccharides competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Human Milk Oligosaccharides (HMO) are a class of complex carbohydrates naturally found in human breast milk. They are composed of multiple sugar units linked by glycosidic bonds. HMOs are one of the most abundant components in human milk after fat, protein, and lactose, and their concentration is significantly higher in human milk compared to other mammals. HMOs play a crucial role in infant health, serving as prebiotics that promote the growth of beneficial bacteria, such as bifidobacteria, helping to establish a healthy gut microbiome and enhance immune system function.
HMOs vary in structure, including monosaccharides, disaccharides, trisaccharides, and longer polysaccharide chains. Different types of HMOs have distinct biological functions, helping to combat pathogen invasion, reduce inflammation, and support brain development. While HMOs are primarily found in human milk, advances in technology have made it possible to extract and synthesize these oligosaccharides through fermentation and chemical processes for use in commercial products like infant formula, functional foods, and health supplements.
With ongoing research into the benefits of HMOs in infant health and other wellness applications, the demand for human milk oligosaccharides has been steadily increasing, particularly in infant formula and adult prebiotic foods.
Market Development Opportunities and Key Drivers:
As consumer awareness of health increases, especially in regard to infant health, the market for human milk oligosaccharides (HMOs) is experiencing significant growth opportunities. In recent years, extensive research on the role of HMOs in infant health has led more infant formula manufacturers to incorporate HMOs into their products to support immune function and gut health. Additionally, HMOs have shown potential in adult health applications, particularly in maintaining gut microbiome balance and enhancing immune function, opening new growth avenues for the market. As the global population ages and the demand for functional foods rises, there is also growing demand for prebiotic products targeting adults.
Market Risks:
Despite the promising outlook for the HMO market, there are several risks. First, the production of HMOs is complex and costly, which may hinder product accessibility and price competitiveness. Second, the HMO supply chain is intricate, involving multiple stages such as raw material extraction and fermentation. Any technological challenges or disruptions in production could affect the stability of the entire supply chain. Moreover, global regulatory and standard differences may pose challenges to market expansion, particularly in terms of varying regulatory policies and certification requirements in different countries.
Market Concentration:
Currently, the HMO production market is relatively concentrated, with several leading biotech and pharmaceutical companies dominating the industry. These companies have advanced fermentation and biosynthesis technologies that enable large-scale production while maintaining high quality. However, as technology advances and the market expands, more small and medium-sized enterprises are expected to enter the market, fostering competition and innovation.
Downstream Demand Trends:
The downstream demand for HMOs is mainly concentrated in infant formula, prebiotic foods and supplements, and personalized nutrition products. As consumers increasingly demand personalized and functional nutrition products, the market for HMOs as a functional ingredient will continue to grow. Additionally, the potential for HMOs in aging populations is being recognized, particularly for supporting gut health and immune systems in elderly individuals.
Latest Technologies:
The production technology for HMOs is continually evolving, with innovations in fermentation and biosynthesis reducing production costs. Furthermore, the application of genetic engineering and synthetic biology has opened up possibilities for customized HMO production, allowing for optimized efficiency and yields through genetically modified microorganisms.
This report delivers a comprehensive overview of the global Human Milk Oligosaccharides market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Human Milk Oligosaccharides. The Human Milk Oligosaccharides market size, estimates, and forecasts are provided in terms of sales volume (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Human Milk Oligosaccharides market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Human Milk Oligosaccharides manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Human Milk Oligosaccharides manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Human Milk Oligosaccharides sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Human Milk Oligosaccharides Market Overview
1.1 Product Definition
1.2 Human Milk Oligosaccharides by Type
1.2.1 Global Human Milk Oligosaccharides Market Value by Type: 2025 vs 2032
1.2.2 Fucosyllactose
1.2.3 LNT & LNNT
1.2.4 Sialyllactose
1.3 Human Milk Oligosaccharides by Application
1.3.1 Global Human Milk Oligosaccharides Market Value by Application: 2025 vs 2032
1.3.2 Infant Formula
1.3.3 Other Applications
1.4 Global Human Milk Oligosaccharides Market Size Estimates and Forecasts
1.4.1 Global Human Milk Oligosaccharides Revenue 2021–2032
1.4.2 Global Human Milk Oligosaccharides Sales 2021–2032
1.4.3 Global Human Milk Oligosaccharides Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Human Milk Oligosaccharides Market Competition by Manufacturers
2.1 Global Human Milk Oligosaccharides Sales Market Share by Manufacturers (2021–2026)
2.2 Global Human Milk Oligosaccharides Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Human Milk Oligosaccharides Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Human Milk Oligosaccharides, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Human Milk Oligosaccharides, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Human Milk Oligosaccharides, Product Types and Applications
2.7 Global Key Manufacturers of Human Milk Oligosaccharides, Date of Entry into the Industry
2.8 Global Human Milk Oligosaccharides Market Competitive Situation and Trends
2.8.1 Global Human Milk Oligosaccharides Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Human Milk Oligosaccharides Players Market Share by Revenue
2.8.3 Global Human Milk Oligosaccharides Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Human Milk Oligosaccharides Market Scenario by Region
3.1 Global Human Milk Oligosaccharides Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Human Milk Oligosaccharides Sales by Region: 2021–2032
3.2.1 Global Human Milk Oligosaccharides Sales by Region: 2021–2026
3.2.2 Global Human Milk Oligosaccharides Sales by Region: 2027–2032
3.3 Global Human Milk Oligosaccharides Revenue by Region: 2021–2032
3.3.1 Global Human Milk Oligosaccharides Revenue by Region: 2021–2026
3.3.2 Global Human Milk Oligosaccharides Revenue by Region: 2027–2032
3.4 North America Human Milk Oligosaccharides Market Facts & Figures by Country
3.4.1 North America Human Milk Oligosaccharides Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Human Milk Oligosaccharides Sales by Country (2021–2032)
3.4.3 North America Human Milk Oligosaccharides Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Milk Oligosaccharides Market Facts & Figures by Country
3.5.1 Europe Human Milk Oligosaccharides Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Human Milk Oligosaccharides Sales by Country (2021–2032)
3.5.3 Europe Human Milk Oligosaccharides Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Milk Oligosaccharides Market Facts & Figures by Region
3.6.1 Asia Pacific Human Milk Oligosaccharides Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Human Milk Oligosaccharides Sales by Region (2021–2032)
3.6.3 Asia Pacific Human Milk Oligosaccharides Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Milk Oligosaccharides Market Facts & Figures by Country
3.7.1 Latin America Human Milk Oligosaccharides Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Human Milk Oligosaccharides Sales by Country (2021–2032)
3.7.3 Latin America Human Milk Oligosaccharides Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Milk Oligosaccharides Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Milk Oligosaccharides Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Human Milk Oligosaccharides Sales by Country (2021–2032)
3.8.3 Middle East and Africa Human Milk Oligosaccharides Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Milk Oligosaccharides Sales by Type (2021–2032)
4.1.1 Global Human Milk Oligosaccharides Sales by Type (2021–2026)
4.1.2 Global Human Milk Oligosaccharides Sales by Type (2027–2032)
4.1.3 Global Human Milk Oligosaccharides Sales Market Share by Type (2021–2032)
4.2 Global Human Milk Oligosaccharides Revenue by Type (2021–2032)
4.2.1 Global Human Milk Oligosaccharides Revenue by Type (2021–2026)
4.2.2 Global Human Milk Oligosaccharides Revenue by Type (2027–2032)
4.2.3 Global Human Milk Oligosaccharides Revenue Market Share by Type (2021–2032)
4.3 Global Human Milk Oligosaccharides Price by Type (2021–2032)
5 Segment by Application
5.1 Global Human Milk Oligosaccharides Sales by Application (2021–2032)
5.1.1 Global Human Milk Oligosaccharides Sales by Application (2021–2026)
5.1.2 Global Human Milk Oligosaccharides Sales by Application (2027–2032)
5.1.3 Global Human Milk Oligosaccharides Sales Market Share by Application (2021–2032)
5.2 Global Human Milk Oligosaccharides Revenue by Application (2021–2032)
5.2.1 Global Human Milk Oligosaccharides Revenue by Application (2021–2026)
5.2.2 Global Human Milk Oligosaccharides Revenue by Application (2027–2032)
5.2.3 Global Human Milk Oligosaccharides Revenue Market Share by Application (2021–2032)
5.3 Global Human Milk Oligosaccharides Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Company Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Human Milk Oligosaccharides Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Abbott Human Milk Oligosaccharides Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Dupont (Inbiose)
6.2.1 Dupont (Inbiose) Company Information
6.2.2 Dupont (Inbiose) Description and Business Overview
6.2.3 Dupont (Inbiose) Human Milk Oligosaccharides Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Dupont (Inbiose) Human Milk Oligosaccharides Product Portfolio
6.2.5 Dupont (Inbiose) Recent Developments/Updates
6.3 DSM (Glycom)
6.3.1 DSM (Glycom) Company Information
6.3.2 DSM (Glycom) Description and Business Overview
6.3.3 DSM (Glycom) Human Milk Oligosaccharides Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 DSM (Glycom) Human Milk Oligosaccharides Product Portfolio
6.3.5 DSM (Glycom) Recent Developments/Updates
6.4 Chr. Hansen (Jennewein)
6.4.1 Chr. Hansen (Jennewein) Company Information
6.4.2 Chr. Hansen (Jennewein) Description and Business Overview
6.4.3 Chr. Hansen (Jennewein) Human Milk Oligosaccharides Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Chr. Hansen (Jennewein) Human Milk Oligosaccharides Product Portfolio
6.4.5 Chr. Hansen (Jennewein) Recent Developments/Updates
6.5 BASF
6.5.1 BASF Company Information
6.5.2 BASF Description and Business Overview
6.5.3 BASF Human Milk Oligosaccharides Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BASF Human Milk Oligosaccharides Product Portfolio
6.5.5 BASF Recent Developments/Updates
6.6 FrieslandCampina
6.6.1 FrieslandCampina Company Information
6.6.2 FrieslandCampina Description and Business Overview
6.6.3 FrieslandCampina Human Milk Oligosaccharides Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 FrieslandCampina Human Milk Oligosaccharides Product Portfolio
6.6.5 FrieslandCampina Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Milk Oligosaccharides Industry Chain Analysis
7.2 Human Milk Oligosaccharides Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Milk Oligosaccharides Production Mode & Process Analysis
7.4 Human Milk Oligosaccharides Sales and Marketing
7.4.1 Human Milk Oligosaccharides Sales Channels
7.4.2 Human Milk Oligosaccharides Distributors
7.5 Human Milk Oligosaccharides Customer Analysis
8 Human Milk Oligosaccharides Market Dynamics
8.1 Human Milk Oligosaccharides Industry Trends
8.2 Human Milk Oligosaccharides Market Drivers
8.3 Human Milk Oligosaccharides Market Challenges
8.4 Human Milk Oligosaccharides Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Human Milk Oligosaccharides market size was US$ 425 million in 2025 and is forecast to reach a readjusted size of US$ 537 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 76
USD 4250.00
(Single User License)
The global Human Milk Oligosaccharides market is projected to grow from US$ 425 million in 2025 to US$ 537 million by 2032, at a CAGR of 3.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-09
Pages: 134
USD 4900.00
(Single User License)
The global market for Human Milk Oligosaccharides was estimated to be worth US$ 425 million in 2025 and is projected to reach US$ 537 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 103
USD 3950.00
(Single User License)
The global Human Milk Oligosaccharides market size was US$ 412 million in 2024 and is forecast to a readjusted size of US$ 521 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 79
USD 4250.00
(Single User License)
The global market for Human Milk Oligosaccharides was estimated to be worth US$ 412 million in 2024 and is forecast to a readjusted size of US$ 521 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published Date: 2025-02-27
Pages: 92
USD 3950.00
(Single User License)
The global market for Human Milk Oligosaccharides was valued at US$ 412 million in the year 2024 and is projected to reach a revised size of US$ 521 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published Date: 2025-01-21
Pages: 82
USD 2900.00
(Single User License)
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Published Date: 2024-04-26
Pages: 95
USD 4900.00
(Single User License)
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Published Date: 2024-01-15
Pages: 78
USD 2900.00
(Single User License)
The global Human Milk Oligosaccharides market size was US$ 425 million in 2025 and is forecast to reach a readjusted size of US$ 537 million by 2032 with a CAGR of 3.4% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 76
The global Human Milk Oligosaccharides market is projected to grow from US$ 425 million in 2025 to US$ 537 million by 2032, at a CAGR of 3.4% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-09
Pages: 134
The global market for Human Milk Oligosaccharides was estimated to be worth US$ 425 million in 2025 and is projected to reach US$ 537 million, growing at a CAGR of 3.4% from 2026 to 2032.
Published: 2026-03-05
Pages: 103
The global Human Milk Oligosaccharides market size was US$ 412 million in 2024 and is forecast to a readjusted size of US$ 521 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 79
The global market for Human Milk Oligosaccharides was estimated to be worth US$ 412 million in 2024 and is forecast to a readjusted size of US$ 521 million by 2031 with a CAGR of 3.4% during the forecast period 2025-2031.
Published: 2025-02-27
Pages: 92
The global market for Human Milk Oligosaccharides was valued at US$ 412 million in the year 2024 and is projected to reach a revised size of US$ 521 million by 2031, growing at a CAGR of 3.4% during the forecast period.
Published: 2025-01-21
Pages: 82
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Published: 2024-04-26
Pages: 95
Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
Published: 2024-01-15
Pages: 78
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now